Adenosine rest-stress perfusion may represent nearly half the imaging volume at some clinics, but due to safety questions some physicians are sticking with dobutamine for pharmacological stress testing.
Adenosine rest-stress perfusion may represent nearly half the imaging volume at some clinics, but due to safety questions some physicians are sticking with dobutamine for pharmacological stress testing.
A study of adenosine safety conducted by researchers at St. Marien Hospital in Bonn, Germany, may put those concerns to rest. Dr. Karol Miszlaski-Jamka did record minor side effects, such as facial flushing and mild shortness of breath, in 81% of the 645 patients who underwent adenosine-stress contrast MR. But major side effects were limited, including 23 cases of transient high-degree atrioventricular block that resolved spontaneously, one case of severely increased blood pressure, and two instances of claustrophobia.
Study affirms safety . . .
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.